explore -WSS

explore

author：leisure time 2025-10-01 05:39:31 - browse：9

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： ASCO Daily Recap: CAR

WSS

Data don't support strong claims for Covid

Eli Lilly’s Zepbound improved liver scarring in mid

Medical experts exlpore how to eliminate bias in clinical algorithms

The most pressing bird flu mysteries scientists want answered

Illumina to lay off 10% of research and development team

Fight over Supreme Court dialysis ruling puts kidney patients at risk

entertainment

explore

explore

In age of alternative facts, a scholarly course on calling out crap

Here's how to stay safe from wildfire smoke amid reduced air quality

What does generative AI mean for health care? We asked experts

Here's how to stay safe from wildfire smoke amid reduced air quality

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT wants to know your pick for a great summer read or listen

Peter Hotez and the public health issue of online harassment

BD to buy Edwards patient monitoring unit for $4.2 billion

In Memoriam: Notable people who died in 2023

Synthetic human embryos? Researchers say term is overblown

hotspot

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

'Little Tech' descents on D.C., wanting a say in how AI is regulated

UnitedHealth wins $3.3 billion takeover of Amedisys

Ukrainian soldiers say they owe lives to US

Structure Therapeutics oral GLP

Medicare Advantage's lean provider networks lead CMS complaints

focus

focus

knowledge

entertainment